Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) shares reached a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $10.58 and last traded at $10.58, with a volume of 300 shares changing hands. The stock had previously closed at $10.1680.
Aspen Pharmacare Stock Performance
The business has a fifty day moving average price of $9.67 and a 200 day moving average price of $8.72. The company has a quick ratio of 1.68, a current ratio of 2.54 and a debt-to-equity ratio of 0.12.
Aspen Pharmacare Company Profile
Aspen Pharmacare is a South African pharmaceutical company headquartered in Durban. Founded in 1997, it develops, manufactures and markets branded and generic medicines for patients and healthcare providers. The company’s product portfolio includes prescription and over-the-counter medicines across a range of therapeutic areas, as well as specialized products such as injectable medicines, anesthetics and treatments for thrombosis. Aspen also operates pharmaceutical manufacturing facilities and supplies medicines to other companies and healthcare markets.
Featured Stories
- Five stocks we like better than Aspen Pharmacare
- Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI Demand
- Alphabet Escalates AI Chip Rivalry With NVIDIA
- Amazon’s Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?
- 3 Stocks Wall Street Likes More Than the Market Does
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
